Evaluation of utility of pharmacokinetic studies in phase I combination trials. ApoStream, a novel device for antibody-independent capture of circulating cancercells (CCCs) from blood of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results